| Medicare CGS | Billing and Coding: Removal of Benign Skin Lesions (57044) | 2026-01-12 |
| Medicare CGS | Billing and Coding: MolDX: Proteomics Testing (59646) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (57037) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Blood Product Molecular Antigen Typing (57124) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing (57268) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Breast Cancer Assay: Prosigna– (57363) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Envisia–, Veracyte–, Idiopathic Pulmonary Fibrosis Diagnostic Test (57419) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (57423) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: MGMT Promoter Methylation Analysis (57432) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (57441) | 2026-01-12 |